Robert Landewe

Prof. PhD

Full Professor, AII - Immunology Affiliatie UvA Associate Professor, Clinical Immunology and Rheumatology

Specialization

Rheumatology

Focus of research

Outcome research in rheumatological diseases in its broadest sense, with a special interest in medical statistics as well as imaging in spondyloarthritis and rheumatoid arthritis

Key publications
Latest publications

Robert Landewe

Specialization

Focus of research

Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort

Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients

Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort

Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort

Robert Landewe

Specialization

Focus of research

Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort

Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients

Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort

Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort

Amsterdam UMC makes use of cookies